Reducing Immunosuppression for BK Polyomavirus–What to do About Corticosteroids?-Reference-Cited by-同舟云学术

Reducing Immunosuppression for BK Polyomavirus–What to do About Corticosteroids?

Published:2024-08-21 Issue:9 Volume:108 Page:e277-e277
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Hirsch Hans H.¹,Pape Lars²,Tedesco Silva Helio³,Kotton Camille N.⁴

Affiliation:

1. Transplantation and Clinical Virology, Department of Biomedicine, University of Basel, Basel, Switzerland.

2. Department of Pediatrics II, University Hospital of Essen, University of Duisburg-Essen, Essen, Germany.

3. Division of Nephrology, Hospital do Rim, Fundação Oswaldo Ramos, Paulista School of Medicine, Federal University of São Paulo, São Paulo, Brazil.

4. Transplant and Immunocompromised Host Infectious Diseases Unit, Infectious, Diseases Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference6 articles.

1. The second international consensus guidelines on the management of BK polyomavirus in kidney transplantation.;Kotton;Transplantation,2024

2. Polyomavirus BK replication dynamics in vivo and in silico to predict cytopathology and viral clearance in kidney transplants.;Funk;Am J Transplant,2008

3. Stress steroids are not required for patients receiving a renal allograft and undergoing operation.;Bromberg;J Am Coll Surg,1995

4. Adrenal insufficiency in kidney transplant patients during low-dose prednisolone therapy: a cross-sectional case-control study.;Valentin;Nephrol Dial Transplant,2020

5. Unintended consequences: risk of opportunistic infections associated with long-term glucocorticoid therapies in adults.;Chastain;Clin Infect Dis,2024